Racial Differences in the Expression of Shared Idiotypes by Paraproteins from Patients with Monoclonal Gammopathies

  • J. R. Berenson
  • A. K. Lichtenstein
  • J. Cao
  • S. Hart
  • D. Palomares
  • R. A. Miller
Conference paper


Twenty-nine murine monoclonal antibodies have been produced which react with shared idiotypes expressed by B-cell lymphomas and leukemias. We tested this panel of antibodies for reactivity with the paraproteins from 37 patients with multiple myeloma and 13 patients with monoclonal gammopathy of undetermined significance (MGUS). Fourteen of 50 paraproteins reacted with at least one antibody in this panel of anti-idiotypic antibodies. Seven different anti-idiotypes demonstrated reactivity with the paraproteins. A similar frequency of reactivity was found for both myeloma and MGUS proteins. One antibody, S30–47, reacted with eight (16%) of the paraproteins from patients with these monoclonal gammopathies; whereas, this anti-idiotype only bound to 3% of non-Hodgkin’s B-cell lymphomas and no cases of chronic lymphocytic leukemia. This antibody demonstrated reactivity with paraproteins obtained from nearly one-third of black patients but none of the white patients’ paraproteins showed reactivity with this antiidiotype. In each of eleven patients tested, plasma cells isolated from bone marrow were shown to be reactive with the same anti-idiotype we found to react with the paraprotein. Anti-shared idiotype antibodies may provide useful reagents for studies of patients with monoclonal gammopathies.


Multiple Myeloma Chronic Lymphocytic Leukemia Bone Marrow Plasma Cell Idiotypic Determinant Chain Variable Region Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Antin JH, Emerson SG, Martin P, Gadol N, Ault KA (1975) Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: Phenotypic and functional studies. J Immunol 136:505–510Google Scholar
  2. Blattner WA (1980) Epidemiology of multiple myeloma and related plasma cell disorders: An analytic review. In: Potter M, ed. Progress in myeloma. New York:Elsevier/North Holland, Inc. p 1–65Google Scholar
  3. Bofill M, Janossy G, Janossa M, Burford GD, Seymour GJ, Wernet P, Kelemen E (1985) Human B cell development: II. Subpopulations in the human fetus. J Immunol 134:1531–1538PubMedGoogle Scholar
  4. Brown S, Miller RA, Horning SJ, Czerwinski D, Hart SM, McElderry R, Basham T, Warnke R, Merigan TC, Levy R (1989) Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 73:651–661PubMedGoogle Scholar
  5. Carrol WL, Thielemans K, Dilley J, Levy R (1986) Mouse x human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods 89:61–72CrossRefGoogle Scholar
  6. Cleary ML, Meeker TC, Levy S, Lee E, Trela M, Sklar J, Levy R (1986) Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44:97–106PubMedCrossRefGoogle Scholar
  7. Committee of the Chronic Leukemia-Myeloma Task Force (1973) Proposed Guidelines for Protocol Studies. II. Plasma cell myeloma. Cancer Chemother Rep 4:145–158Google Scholar
  8. Davidson A, Preud’homme JL, Solomon A, Chang MDY, Beede S, Diamond B (1987) Idiotypic analysis of myeloma proteins: anti-DNA activity of monoclonal immunoglobulins bearing an SLE idiotype is more common in IgG than IgM antibodies. J Immunol 138:1515–1518PubMedGoogle Scholar
  9. Duperray C, Klein B, Durie BGM, Zhang X, Jourdan M, Poncelet P, Favier F, Vincent C, Brochier J, Lenoir G, Bataille R (1989) Phenotypic analysis of human myeloma cell lines. Blood 73:566–572PubMedGoogle Scholar
  10. Goni F, Chen PP, Pons-Estel B, Carson DA, Frangione B (1985) Sequence similarities and cross-idiotypic specificity of L chains among human monoclonal IgM-K with anti-globulin activity. J Immunol 135: 4073–4079PubMedGoogle Scholar
  11. Gonzalez-Cabrero, Egido J, Sancho J, Moldenhauer F (1987) Presence of shared idiotypes in serum and immune complexes in patients with IgA nephropathy. Clin Exp Immunol 68:694–702PubMedGoogle Scholar
  12. Humphries CG, Shen A, Kuziel WA, Capra JD, Blattner FR, Tucker PW (1988) A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumours. Nature 331:446–449PubMedCrossRefGoogle Scholar
  13. Isenberg DA, Shoenfeld Y, Madaio MP, Rauch J, Reichlin M, Stollar BD, Schwartz RS (1984) Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet ii:417–422CrossRefGoogle Scholar
  14. Kim S, Davis M, Sinn E, Patten P, Hood L (1981) Antibody diversity: somatic hypermutation of rearranged VH. genes. Cell 27:573–581Google Scholar
  15. Kipps TJ (1988) Immunoglobulin V gene utilization in chronic lymphocytic leukemia and non-Hodgkin’s B cell lymphomas. Nouv Rev Fr Hematol 30:293–298PubMedGoogle Scholar
  16. Kipps TJ, Robbins BA, Kuster P, Carson DA (L988a) Autoantibody- associated cross-reactive idiotypes expressed at high frequency in chronic lymphocytic leukemia relative to B-cell lymphomas of follicular center cell origin. Blood 72:422–428PubMedGoogle Scholar
  17. Kipps TJ, Tomhave E, Chen PP, Carson DA (1988b) Autoantibody- associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation.J Exp Med 167:840–852PubMedCrossRefGoogle Scholar
  18. Kipps TJ, Tomhave E, Pratt LF, Duffy S, Chen PP, Carson D (1989) Developmentally restricted immunoglobulin heavy chain variable region gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 86:5913–5917PubMedCrossRefGoogle Scholar
  19. Krolik KA, Uhr JW, Slavin S, Vitetta ES (1982) In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. J Exp Med 155:1797–1809CrossRefGoogle Scholar
  20. Kubagawa J, Vogler LB, Capra JD, Conrad ME, Lawton AR, Cooper M (1979) Study of the clonal origin of multiple myeloma. J Exp Med 150: 792–807PubMedCrossRefGoogle Scholar
  21. Kunkel HG, Mannik M, Williams RC (1963) Individual antigenic specificity of isolated antibodies. Science 140:1218–1219PubMedCrossRefGoogle Scholar
  22. Kunkel HG, Agnello V, Joslin FG, Winchester RJ, Capra JD (1973) Cross idiotypic specificity among monoclonal IgM proteins with anti-gammaglobulin activity. J Exp Med 137:331–342PubMedCrossRefGoogle Scholar
  23. Kyle RA (1978) Monoclonal gammopathy of undetermined significance: Natural history in 241 cases. Am J Med 64:814–826PubMedCrossRefGoogle Scholar
  24. Mageed RA, Carson DA, Jefferis R (1988) Analysis of rheumatoid factor autoantibodies in patients with essential mixed cryoglobulinaenemia and rheumatoid arthritis. Scand J Rheumatol 75 (Suppl):172–178CrossRefGoogle Scholar
  25. McPhedran P, Heath CW Jr, Garcia J (1972) Multiple myeloma incidence in metropolitan Atlanta, Georgia: Racial and seasonal variations. Blood 39:866–873PubMedGoogle Scholar
  26. Meeker TC, Lowder J, Maloney DG, Miller RA, Thielemans K, Warnke R, Levy R (1985) A clinical trial of anti-idiotype therapy for B cell malignancy. Blood 65:1349–1363PubMedGoogle Scholar
  27. Meeker TC, Grimaldi JG, O’Rourke R, Loeb J, Juliusson G, Einhorn S (1988) Lack of detectable somatic hypermutation in the V region of an Ig H chain gene of a human chronic B lymphocytic leukemia. J Immunol 141:3994–3998PubMedGoogle Scholar
  28. Miller RA, Maloney DG, Warnke R, and Levy R (1982) Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Eng J Med 306:517–522CrossRefGoogle Scholar
  29. Miller RA, Hart S, Samoszuk M, Coulter C, Brown S, Czerwinski D, Lelenberg J, Royston I, Levy R (1989) Shared idiotypes expressed by human B-cell lymphomas. N Eng J Med 321:851–857CrossRefGoogle Scholar
  30. Perek Y, Hurwitz E, Burowski D, Haimovich J (1983) Immunotherapy of a murine B cell tumor with antibodies and F (ab’)2 fragments against idiotypic determinants of its cell surface IgM. J Immunol 131: 1600–1603PubMedGoogle Scholar
  31. Stevenson GT, Elliot EV, Stevenson FK (1977) Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc 36:2268–2271PubMedGoogle Scholar
  32. Stevenson GT and Stevenson FK (1975) Antibody to a molecularly-defined antigen confined to a tumour cell surface. Nature 254:714–716PubMedCrossRefGoogle Scholar
  33. Thielemans K, Maloney DG, Meeker T, Fujimoto J, Doss C, Warnke RA, Bindl J, Gralow J, Miller RA, Levy R (1984) Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas. J Immunol 133:495–501PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • J. R. Berenson
    • 1
  • A. K. Lichtenstein
    • 1
  • J. Cao
    • 1
  • S. Hart
    • 2
  • D. Palomares
    • 2
  • R. A. Miller
    • 2
  1. 1.Department of Medicine, Wadsworth and Jonsson Cancer CentersUCLA School of Medicine and VA West Los AngelesLos AngelesUSA
  2. 2.IDEC Pharmaceuticals CorporationMountain ViewUSA

Personalised recommendations